Contact number
+86 21 6030 0600Provided by Chambers
Cooley LLP's life sciences department is a strong transactional outfit that advises pharmaceutical and biotechnology companies. The team is sought after by investors for assistance on acquisitions, investments, M&A and licensing agreements. Its additional strengths include advice on joint venture formation and cross-border capital markets transactions as well as regulatory matters.
Provided by Cooley LLP
Cooley advised Jiangsu Hengrui Pharmaceuticals on its exclusive licensing agreement with the Germany-based company Merck to develop, manufacture and commercialise Hengrui's next-generation potent and selective PARP1 inhibitor, HRS-1167.
Provided by Chambers
Cooley understands our business needs and are really quick to provide solutions.
They have great combined experience in and out of China, which is important for a deal with global partners.
Cooley's service is very professional, and their response is always faster than expected. They have many experienced professionals to provide an opinion or help with execution.
Cooley understands our business needs and are really quick to provide solutions.
They have great combined experience in and out of China, which is important for a deal with global partners.
Cooley's service is very professional, and their response is always faster than expected. They have many experienced professionals to provide an opinion or help with execution.
Provided by Chambers
Liu Yiming is noted for actively assisting with licensing agreements and cross-border transactions including acquisitions, joint ventures and IPOs. With an impressive background in biology and health services, he attracts big-name investors and world-leading pharmaceutical companies.
Liu Yiming is our go-to counsel, he is well-rounded and provides comprehensive legal services.